Business, Healthcare, Lifestyle, Science

Zoetis announces US label update for Librela® (bedinvetmab injection), a treatment to control canine osteoarthritis (OA) pain

Zoetis plans to immediately implement updated label based on U.S. post-approval experience with Librela Company remains confident in the safety and effectiveness of Librela and reaffirms its commitment to supporting veterinarians and pet owners in helping dogs with OA live with less

Business, Law & Legal, Lifestyle, Sponsored Content

EPIX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC announces that ESSA Pharma Inc. investors with substantial losses have opportunity to lead class action lawsuit

NEW YORK — (BUSINESS WIRE) — $EPIX #EPIX — Attorney Advertising — Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against ESSA Pharma Inc. (“ESSA” or “the Company”) (NASDAQ: EPIX)

Business, Law & Legal, Sponsored Content

CDLX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC announces that Cardlytics, Inc. investors with substantial losses have opportunity to lead class action lawsuit

NEW YORK — (BUSINESS WIRE) — $CDLX #CDLX  — Attorney Advertising — Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Cardlytics, Inc. (“Cardlytics” or “the Company”) (NASDAQ: CDLX) and